The Procter & Gamble Company growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +3.3%
EBITDA: +6.8%
EBIT: +0.9%
EPS: +8.0%
Free cash flow: +0.0%
Operating cash flow: +4.4%

Forward estimates

Revenue: +2.9%
EBITDA: +5.9%
EPS: +5.0%

Three-year CAGR

Revenue: +1.7%
EBITDA: +4.0%
EBIT: +4.7%
Net income: +2.7%
EPS: +3.6%
Free cash flow: +1.2%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.